Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AKR1C3 regulated by NRF2/MAFG complex promotes proliferation via stabilizing PARP1 in hepatocellular carcinoma
Di Pan, Wanwan Yang, Yao Zeng, et al.
Oncogene (2022) Vol. 41, Iss. 31, pp. 3846-3858
Closed Access | Times Cited: 20

Showing 20 citing articles:

The integrated stress response effector ATF4 is an obligatory metabolic activator of NRF2
Julia Katharina Charlotte Kreß, Christina Jessen, Anita Hufnagel, et al.
Cell Reports (2023) Vol. 42, Iss. 7, pp. 112724-112724
Open Access | Times Cited: 53
AKR1C3 suppresses ferroptosis in hepatocellular carcinoma through regulation of YAP/SLC7A11 signaling pathway
Jinsi Chen, Jia Zhang, Wei Tian, et al.
Molecular Carcinogenesis (2023) Vol. 62, Iss. 6, pp. 833-844
Closed Access | Times Cited: 22
AKR1C3 silencing inhibits autophagy‐dependent glycolysis in thyroid cancer cells by inactivating ERK signaling
Ying Gao, Weijie Tao, Shoujun Wang, et al.
Drug Development Research (2024) Vol. 85, Iss. 1
Closed Access | Times Cited: 9
AKR1C3-dependent lipid droplet formation confers hepatocellular carcinoma cell adaptability to targeted therapy
Changqing Wu, Chaoliu Dai, Xinyu Li, et al.
Theranostics (2022) Vol. 12, Iss. 18, pp. 7681-7698
Open Access | Times Cited: 29
The role and regulation of Maf proteins in cancer
Yalan Deng, Liqing Lu, Huajun Zhang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 19
AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies
Mengnan Li, Limin Zhang, Jiahui Yu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
hsa_circ_0008305 facilitates the malignant progression of hepatocellular carcinoma by regulating AKR1C3 expression and sponging miR-379-5p
Shenglan Huang, Kan Liu, Ying Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Structure-guided optimization of 3-hydroxybenzoisoxazole derivatives as inhibitors of Aldo-keto reductase 1C3 (AKR1C3) to target prostate cancer
Agnese Chiara Pippione, Sandra Kovachka, Chiara Vigato, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116193-116193
Open Access | Times Cited: 4
The Relationship between AKR1C3 and Diseases
大中 袁
Hans Journal of Medicinal Chemistry (2025) Vol. 13, Iss. 01, pp. 70-85
Closed Access
A novel feedback regulation loop of METTL11A–MAFG–NPL4 promotes bladder cancer cell proliferation and tumor progression
Bao‐Sai Lu, Kai-long Liu, yongcheng Yin, et al.
The FASEB Journal (2025) Vol. 39, Iss. 7
Closed Access
Insulin-Induced AKR1C3 Induces Fatty Acid Synthase in a Model of Human PCOS Adipocytes
Ryan D. Paulukinas, T.M. Penning
Endocrinology (2023) Vol. 164, Iss. 5
Closed Access | Times Cited: 9
Inflammation dynamically regulates steroid hormone metabolism and action within macrophages in rheumatoid arthritis
Claire Martin, A Crastin, M S Sagmeister, et al.
Journal of Autoimmunity (2024) Vol. 147, pp. 103263-103263
Open Access | Times Cited: 3
A novel myeloid cell marker genes related signature can indicate immune infiltration and predict prognosis of hepatocellular carcinoma: Integrated analysis of bulk and single-cell RNA sequencing
Su-Su Zheng, Yanfang Wu, Boheng Zhang, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 4
In vitro evaluation of the reductive carbonyl idarubicin metabolism to evaluate inhibitors of the formation of cardiotoxic idarubicinol via carbonyl and aldo–keto reductases
Gzona Bajraktari‐Sylejmani, Julia Sophie Oster, Jürgen Burhenne, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 3, pp. 807-820
Open Access | Times Cited: 1
AKR1C3 promotes progression and mediates therapeutic resistance by inducing epithelial-mesenchymal transition and angiogenesis in small cell lung cancer
Wenting Liu, Guoli Li, Dingzhi Huang, et al.
Translational Oncology (2024) Vol. 47, pp. 102027-102027
Open Access | Times Cited: 1
A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma
Yanbing Yang, Xuenian Ye, Haibin Zhang, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 3
AKR1C3 protects cardiomyocytes against hypoxia-induced cell apoptosis through the Nrf-2/NF-κB pathway
Wenlu Zhang, Wei Tian, Xin Xia, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access
Exosomal miR-184 facilitates bladder cancer progression by targeting AKR1C3 and inducing immune escape via IRF2-CXCL10 axis
Wenwei Ying, Yongchao Zhao, Yuhui He, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1871, Iss. 3, pp. 167627-167627
Open Access
HBXIP induces PARP1 via WTAP-mediated m6A modification and CEBPA-activated transcription in cisplatin resistance to hepatoma
Xueli Fu, Shi-man Guo, Jiaqi Ma, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2405-2419
Closed Access
The ameliorative effects and underlying mechanisms of Lactobacillus plantarum on glyoxal-induced cytotoxicity
Mu Yang, Siyu Guo, Fangyi Chen, et al.
Food Bioscience (2024), pp. 105806-105806
Closed Access
Page 1

Scroll to top